Skip to main content
. Author manuscript; available in PMC: 2021 Apr 9.
Published in final edited form as: Cancer Health Disparities. 2019 Aug 19;3:e1–e12.

Table 1.

Patient characteristics by region.

Characteristics Total (N=43,637) Region p-value
US14 (N=36,182) South (N=7,455)
Age at diagnosis (%)
Mean (SD) 63.3 (15.8) 63.4 (15.7) 62.5 (15.9) <0.0001
Median (IQR) 64.0 (53,76) 64 (53, 76) 63 (52, 75)
> 65 21,034 (48.2) 48.4% 47.0% 0.03
< 65 22,603 (51.8) 51.6% 53.0%
Cancer stage (%) <0.0001
0 81 (0.2) 68 (0.2) 13 (0.2)
I 8,447 (19.6) 7,062 (19.8) 1,385 (18.9)
II 3,001 (7.0) 2,441 (6.8) 560 (7.6)
III 13,008 (30.2) 10,779 (25.3) 2,229 (30.4)
IV 11,036 (25.7) 9,028 (25.3) 2,008 (27.4)
Unstaged 7,445 (17.3) 6,302 (17.7) 1,143 (15.6)
Grouped Cancer stage (%) <0.0001
Stage 0–II 11,529 (26.8) 9,571 (26.8) 1,958 (26.7)
Stage III–IV 24,044 (55.9) 19,807 (55.5) 4,237 (57.7)
Unstaged 7,445 (17.3) 6,302 (17.7) 1,143 (15.6)
Surgery <0.0001
Yes 32,786 (75.7) 27,347 (76.2) 5,439 (73.4)
No 10,529 (24.3) 8,558 (23.8) 1,971 (26.6)
Insurance (%)
Insured 8,703 (96.6) 7,154 (97.3) 1,549(93.4)
Uninsured 306 (3.4) 197 (2.7) 109 (6.6)
5-year survival◊ <0.0001
Yes 17,331 (39.7) 14,575 (40.3) 2,756 (37.0)
No 26,306 (60.3) 21,607 (59.7) 4,699 (63.0)

Only available for cases diagnosed after 2007